Cargando…
Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants
The largest proportion of hereditary melanoma cases are due to pathogenic variants (PVs) in the CDKN2A/p16 gene, which account for 20%-40% of familial melanomas and confer up to a 30%-70% lifetime risk for melanoma in individuals with these variants. In addition, PVs in the CDKN2A gene also increase...
Autores principales: | Pauley, Kristen, Khan, Ambreen, Kohlmann, Wendy, Jeter, Joanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967159/ https://www.ncbi.nlm.nih.gov/pubmed/35372037 http://dx.doi.org/10.3389/fonc.2022.837057 |
Ejemplares similares
-
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
por: Llach, Joan, et al.
Publicado: (2023) -
Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier
por: Martínez de Juan, Fernando, et al.
Publicado: (2017) -
Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in
CDKN2A
mutation carriers and non‐carriers
por: Pissa, Maria, et al.
Publicado: (2022) -
Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders
por: Vagher, Jennie, et al.
Publicado: (2022) -
Surveillance, CDKN2A and survival of familial melanoma
por: van Doorn, Remco
Publicado: (2023)